Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Announces $1B Share Repurchase Plan

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that its board of directors has approved a new $1 billion share repurchase program.

Concurrently, the company also announced a $.15 per share quarterly dividend.

The repurchase authorization allows Thermo Fisher to buy $1 billion of its common stock in both the open market and through negotiated transactions, and replaces an existing authorization that had roughly $410 million remaining. Thermo Fisher said that it intends to begin repurchasing its stock in 2016. 

Thermo recently reported that it had cash and cash equivalents totaling roughly $503 million as of Sept. 26.

The cash dividend, meantime, will be paid on Jan. 15, 2016 to shareholders on record as of Dec. 15, 2015, Thermo said.

During midday trading on the Nasdaq, shares of Thermo Fisher were up $.26 at $132.70.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more